United States · FDA National Drug Code directory
Lialda
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-476_405a190f-df13-4578-a988-5b291b284f21
- Product NDC
- 54092-476
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- mesalamine
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20070116
- Source listing expiry
- 20271231
Source-listed ingredients
- MESALAMINE — 1.2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01) · 54092-476-01
- 12 BOTTLE in 1 CARTON (54092-476-02) / 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-01) · 54092-476-02
- 3 CARTON in 1 CARTON (54092-476-08) / 8 BLISTER PACK in 1 CARTON / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK · 54092-476-08
- 120 TABLET, DELAYED RELEASE in 1 BOTTLE (54092-476-12) · 54092-476-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →